Division of Hematology-Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwando-ro, Dong-gu, 44033, Ulsan, Republic of Korea.
Medical Information Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
BMC Palliat Care. 2021 Apr 27;20(1):63. doi: 10.1186/s12904-021-00759-6.
Cancer is a leading cause of death in Korea. To protect the autonomy and dignity of terminally ill patients, the Life-Sustaining Treatment Decision-Making Act (LST-Act) came into full effect in Korea in February 2018. However, it is unclear whether the LST-Act influences decision- making process for life-sustaining treatment (LST) for terminally ill cancer patients.
This was a retrospective study conducted with a medical record review of cancer patients who died at Ulsan University Hospital between July 2015 and May 2020. Patients were divided into two groups: those who died in the period before the implementation of the LST-Act (from July 2015 to October 2017, Group 1) and after the implementation of the LST-Act (from February 2018 to May 2020, Group 2). We measured the self-determination rate and the timing of documentation of do-not-resuscitate (DNR) or Physician Orders for Life-Sustaining Treatment (POLST) in both groups.
A total of 1,834 patients were included in the analysis (Group 1, n = 943; Group 2, n = 891). Documentation of DNR or POLST was completed by patients themselves in 1.5 and 63.5 % of patients in Groups 1 and 2, respectively (p < 0.001). The mean number of days between documentation of POLST or DNR and death was higher in Group 2 than in Group 1 (21.2 days vs. 14.4 days, p = 0.001). The rate of late decision, defined as documentation of DNR or POLST within 7 days prior to death, decreased significantly in Group 2 (56.1 % vs. 47.6 %, p < 0.001). In the multivariable analysis, female patients (odds ratio [OR] 0.71, p = 0.002) and patients with more than 12 years of education (OR 0.70, p = 0.019) were significantly related to a reduced rate of late decision. More than 12 years of education (OR 0.53, p = 0.018) and referral to hospice palliative care (OR 0.40, p < 0.001) were significantly related to self-determination. Enforcement of LST-Act was related to a reduced rate of surrogate decision-making (OR 0.01, p < 0.001) and late decision (OR 0.51, p < 0.001). However, physicians with clinical experience of less than 3 years had a higher rate of surrogate decision-making (OR 5.08, p = 0.030) and late decision (OR 2.47, p = 0.021).
After the implementation of the LST-Act, the rate of self-determination increased and decisions for LST occurred earlier than in the era before the implementation of the LST-Act.
癌症是韩国的主要死亡原因之一。为了保护终末期患者的自主权和尊严,《维持生命治疗决策法》(LST 法案)于 2018 年 2 月在韩国全面生效。然而,目前尚不清楚 LST 法案是否会影响终末期癌症患者的维持生命治疗(LST)决策过程。
这是一项回顾性研究,对 2015 年 7 月至 2020 年 5 月期间在蔚山大学医院死亡的癌症患者的病历进行了审查。患者分为两组:一组是在 LST 法案实施前(2015 年 7 月至 2017 年 10 月,第 1 组),另一组是在 LST 法案实施后(2018 年 2 月至 2020 年 5 月,第 2 组)死亡的患者。我们测量了两组患者自主决定率和不复苏(DNR)或医生维持生命治疗指令(POLST)记录的时间。
共有 1834 名患者纳入分析(第 1 组,n=943;第 2 组,n=891)。第 1 组和第 2 组中,分别有 1.5%和 63.5%的患者自己完成了 DNR 或 POLST 的记录(p<0.001)。第 2 组 POLST 或 DNR 记录与死亡之间的平均天数高于第 1 组(21.2 天 vs. 14.4 天,p=0.001)。第 2 组晚期决策(即在死亡前 7 天内记录 DNR 或 POLST)的比例显著下降(56.1% vs. 47.6%,p<0.001)。多变量分析显示,女性(比值比 [OR] 0.71,p=0.002)和接受过 12 年以上教育的患者(OR 0.70,p=0.019)与晚期决策的减少显著相关。接受过 12 年以上教育(OR 0.53,p=0.018)和转介临终关怀(OR 0.40,p<0.001)与自主决策显著相关。LST 法案的实施与替代决策(OR 0.01,p<0.001)和晚期决策(OR 0.51,p<0.001)的减少显著相关。然而,临床经验少于 3 年的医生有更高的替代决策(OR 5.08,p=0.030)和晚期决策(OR 2.47,p=0.021)的比例。
LST 法案实施后,自主决策的比例增加,LST 决策的时间早于法案实施前。